© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
September 06, 2011
Johan Lennartsson's research focuses on platelet-derived growth factor receptor (PDGFR) and mitogen-activated protein kinase (MAPK) signaling in normal physiology and cancer.
September 02, 2011
The breadth of the stem cell factor (SCF)/ KIT signaling pathway oncogenic functions and potential role as a therapeutic target are just now becoming clear.
August 31, 2011
The 2 upcoming conferences include the 7th Annual Multidisciplinary Symposium on Head and Neck Cancer and the School of Breast Oncology.
August 24, 2011
It's hard to tell which moves more quickly: Edith Perez's feet, or her mind.
August 22, 2011
Biological markers that help clinicians choose which treatment options to pursue for particular patients are attracting increased research interest.
August 16, 2011
Biomarkers offer great potential for improving management of cancer at every point from screening and detection, to diagnosis, staging, prognosis, and the assessment of treatment response.
August 10, 2011
Amid a continuing emphasis on targeted therapies, pharmaceutical companies have approximately 300 drugs in phase II or later-stage development for cancer treatment.
As personalized medicine occupies a growing role in the pharmaceutical pipeline, major companies are changing their research and development paradigms.
August 09, 2011
The oncology community is quite conversant with the clinical utility of prognostic tumor markers.